CEO of Cytura is Dr Ad van Gorp
He is the founder and former CEO of Dutch Lead Pharma and was member of Kiadis Pharma management team.
Van Gorp is skilled in Physiology, Pharmacology, Biotechnology and Drug Development. He is a strong entrepreneurial professional graduated from University of Utrecht and obtained his PhD from the university of Maastricht.
In close collaboration with Centre for Drug Design and Discovery (CD3) of the KU Leuven and Amsterdam UMC, Van Gorp aspires to advance Cytura’s innovative first-in-class therapies targeting genomic instability of cancers.